Acute development of EBV+ T-cell lymphoproliferative disorder after treatment with rituximab for follicular lymphoma

Satoko Oka, Yuta Watanabe, Yuina Ueda-Akagi, Takaya Mitsuyoshi, Kazuo Ono

Open source

DOI
10.1016/j.jiac.2026.103057
Published
2026-10
Container
Journal of Infection and Chemotherapy
Publisher
Elsevier BV
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.jiac.2026.103057,
  title = {Acute development of EBV+ T-cell lymphoproliferative disorder after treatment with rituximab for follicular lymphoma},
  author = {Satoko Oka and Yuta Watanabe and Yuina Ueda-Akagi and Takaya Mitsuyoshi and Kazuo Ono},
  year = {2026},
  journal = {Journal of Infection and Chemotherapy},
  doi = {10.1016/j.jiac.2026.103057},
  url = {https://doi.org/10.1016/j.jiac.2026.103057}
}

RIS

TY  - JOUR
TI  - Acute development of EBV+ T-cell lymphoproliferative disorder after treatment with rituximab for follicular lymphoma
AU  - Satoko Oka
AU  - Yuta Watanabe
AU  - Yuina Ueda-Akagi
AU  - Takaya Mitsuyoshi
AU  - Kazuo Ono
PY  - 2026
JO  - Journal of Infection and Chemotherapy
DO  - 10.1016/j.jiac.2026.103057
UR  - https://doi.org/10.1016/j.jiac.2026.103057
ER  - 

APA

Oka, S., Watanabe, Y., Ueda-Akagi, Y., Mitsuyoshi, T., & Ono, K. (2026). Acute development of EBV+ T-cell lymphoproliferative disorder after treatment with rituximab for follicular lymphoma. Journal of Infection and Chemotherapy. https://doi.org/10.1016/j.jiac.2026.103057

Source records